Fujian Aonong Biological Technology Group Incorporation Limited (SHA:603363)

China · Delayed Price · Currency is CNY

2.810

+0.040 (1.44%)

Jul 31, 2026, 3:00 PM CST

SHA:603363 Financials Overview

Financials in millions CNY. Fiscal year is January - December.

Millions CNY. Fiscal year is Jan - Dec.

Revenue & Profits

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Revenue	8,897	8,475	8,763	19,458	21,613	18,038
Revenue Growth	9.33%	-3.29%	-54.96%	-9.97%	19.82%	56.62%
Gross Profit	461.05	518.85	395.6	-1,309	657.28	-170.49
Operating Income	-185.28	-109.9	-849.59	-2,600	-628.17	-1,272
Net Income	-154.01	77.62	579.35	-3,651	-1,038	-1,520
Earnings Per Share	-0.07	0.03	0.67	-4.21	-1.34	-2.34
EPS Growth	-	-95.52%	-	-	-	-

Revenue by Segment

Fiscal Year	FY 2025
Period Ending	Dec '25 Dec 31, 2025
Feed and Animal Protection	6,566
Feeding	1,569
Trading	31.15
Food	1,093
Others	13
Offsets between Branches	-797.85
Total	8,475

Cash & Debt

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Investments	440.86	698.68	1,386	212.26	721.69	543.98
Total Debt	2,340	2,329	2,915	8,259	9,273	9,362
Net Cash (Debt)	-1,899	-1,631	-1,530	-8,047	-8,552	-8,818
Net Cash Growth	-	-	-	-	-	-
Net Cash Per Share	-0.85	-0.63	-1.77	-9.28	-11.04	-13.58

Cash Flow & CapEx

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Operating Cash Flow	381.31	152.94	-116.78	984.01	663.64	524.29
Capital Expenditures	-184.05	-232.9	-262.68	-511.77	-1,499	-2,709
Free Cash Flow	197.26	-79.95	-379.46	472.23	-835.31	-2,184
Free Cash Flow Growth	-	-	-	-	-	-

Margins

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Gross Margin	5.18%	6.12%	4.52%	-6.73%	3.04%	-0.95%
Operating Margin	-2.08%	-1.30%	-9.70%	-13.36%	-2.91%	-7.05%
Pretax Margin	-1.78%	1.24%	0.96%	-18.92%	-5.99%	-10.10%
Profit Margin	-1.73%	0.92%	6.61%	-18.76%	-4.80%	-8.43%
FCF Margin	2.22%	-0.94%	-4.33%	2.43%	-3.86%	-12.11%

Valuation

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Aug '26 Aug 2, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
PE Ratio	-	154.59	15.92	-	-	-
Forward PE	-	2.31	2.31	16.41	10.83	7.90
P/FCF Ratio	38.90	-	-	11.19	-	-
PS Ratio	0.86	1.42	1.05	0.27	0.52	0.48